Wani binciken ƙididdiga na lissafin lissafi daga Kwalejin Imperial ta London, kwanan nan aka buga a matsayin bita a cikin LANCETMarubutan sun cire kasar Sin daga tsarinsu, saboda "sakamakon matsayinta na asalin cutar da aka gano" (?) da kuma "babban tasirinsa kan kididdigar mace-macen da aka hana samu daga yawan al'ummarta."
Adadin wadanda suka mutu a duniya a halin yanzu yana kusa 60 miliyan a kowace shekara. Kodayake har yanzu Majalisar Dinkin Duniya ba ta ba da rahoton takamaiman lambobi na 2020 da 2021 ba, duk wani babban motsi da tabbas an lura da shi kuma an tattauna shi sosai a yanzu.
Marubutan Kwalejin Imperial suna son mu yi imani cewa ba tare da allurar COVID-2021 ba, adadin wadanda suka mutu a duniya zai karu da akalla kashi uku a cikin 50 (da sun hada da kasar Sin, da sakamakonsu ya kusan karuwa da kashi 19%), kuma wannan tashin ya kasance gaba daya saboda COVID-XNUMX. Ta yaya wannan ba ze zama abin sha'awa ga kowa ba tare da saura na gama gari da na asibiti?
Kwalejin Imperial da wasu da yawa sun yi fice sosai wajen haɓaka ƙirar acrobatic waɗanda ba su da alaƙa da gaskiya.
Gaskiyar ita ce, babu gunaguni na shaidar asibiti cewa allurar COVID sun ceci rayuka - yawan mace-mace ba a taɓa yin nazari a kowane gwaji da karatunsu ba.
Hana mutuwar ƙungiyar mutane ("Mutuwar Corona"), waɗanda ke mutuwa a matsakaicin shekaru daidai ko sama da matsakaicin shekarun mutuwa a cikin jama'a, na iya zama a zahiri ba zai yiwu ba. Ko ta yaya, duk wani babban tsarin cututtukan cututtuka dole ne yayi lissafi da tattauna adadin shekarun rayuwa da aka samu ta hanyar "ceton" duk waɗannan rayuka.
Duk wani saƙon likita yana da illa. Samfurin daga Kwalejin Imperial ba ya la'akari da wannan kwata-kwata. Hakanan ana samun ci gaba da shaida cewa allurar rigakafin Covid suna haifar da adadi mai muni da lahani. Ba za mu iya ware yuwuwar tasirin tasirin su akan mace-mace - da / ko sama da duka akan shekarun rayuwa da aka samu - hakika korau.
-
Manfred Horst, MD, PhD, MBA, yayi karatun likitanci a Munich, Montpellier da London. Ya shafe mafi yawan aikinsa a masana'antar harhada magunguna, kwanan nan a cikin sashen bincike & ci gaba na Merck & Co/MSD. Tun daga 2017, yana aiki a matsayin mai ba da shawara mai zaman kansa don harhada magunguna, fasahar kere-kere da kamfanonin kiwon lafiya (www.manfred-horst-consulting.com).
Duba dukkan posts
